Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Graffner

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Clinical Pharmacology|January 1, 1983
Plasma concentration of disopyramide given as capsules and controlled release tabletsK Arnman, C Graffner, L Rikner, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Compartment model of prenalterolG Klein, A Wirtzfeld, G Bozler, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1981
Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tabletsC Graffner, P O Lagerström, P N Lundborg, et al.
Pharmaceutical Research|July 1, 1993
In vivo validation of the release rate and palatability of remoxipride-modified release suspensionR Sjöqvist, C Graffner, I Ekman, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterolC Graffner, K J Hoffmann, G Johnsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2000
Development of pectin matrix tablets for colonic delivery of model drug ropivacaineS F Ahrabi, G Madsen, K Dyrstad, et al.
European Journal of Clinical Pharmacology|February 1, 1980
Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in manO Rönn, E Fellenius, C Graffner, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in manO Rönn, C Graffner, G Johnsson, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failureU Dahlström, C Graffner, U Jonsson, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysisU Wiegers, P Hanrath, K H Kuck, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Pharmacology|January 1, 1983
Plasma concentration of disopyramide given as capsules and controlled release tabletsK Arnman, C Graffner, L Rikner, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Compartment model of prenalterolG Klein, A Wirtzfeld, G Bozler, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1981
Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tabletsC Graffner, P O Lagerström, P N Lundborg, et al.
Pharmaceutical Research|July 1, 1993
In vivo validation of the release rate and palatability of remoxipride-modified release suspensionR Sjöqvist, C Graffner, I Ekman, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Pharmacokinetic studies in man of the selective beta 1-adrenoceptor agonist, prenalterolC Graffner, K J Hoffmann, G Johnsson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2000
Development of pectin matrix tablets for colonic delivery of model drug ropivacaineS F Ahrabi, G Madsen, K Dyrstad, et al.
European Journal of Clinical Pharmacology|February 1, 1980
Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in manO Rönn, E Fellenius, C Graffner, et al.
European Journal of Clinical Pharmacology|February 19, 1979
Haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, and its interaction with metoprolol in manO Rönn, C Graffner, G Johnsson, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of prenalterol after single and multiple administration of controlled release tablets to patients with congestive heart failureU Dahlström, C Graffner, U Jonsson, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysisU Wiegers, P Hanrath, K H Kuck, et al.
Pageof 5